| AASLD

Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers

Read more about Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers

Felix Stickel, Philipp Lutz, Stephan Buch, Hans Dieter Nischalke, Ines Silva, Vanessa Rausch, Janett Fischer, Karl Heinz Weiss, Daniel Gotthardt, Jonas Rosendahl, Astrid Marot, Mona Elamly, Marcin Krawczyk, Markus Casper, Frank Lammert, Thomas W. M. Buckley, Andrew McQuillin, Ulrich Spengler, Florian Eyer, Arndt Vogel, Silke Marhenke, Johann Felden, Henning Wege, Rohini Sharma, Stephen Atkinson, Andre Franke, Sophie Nehring, Vincent Moser, Clemens Schafmayer, Laurent Spahr, Carolin Lackner, Rudolf E. Stauber, Ali Canbay, Alexander Link, Luca Valenti, Jane I. Grove, Guruprasad P.

LiverLearning®: 2019 Webinar: The Diverse Presentation and Diagnosis of Liver Injury Due to Drugs or Herbal and Dietary Supplements

Read more about LiverLearning®: 2019 Webinar: The Diverse Presentation and Diagnosis of Liver Injury Due to Drugs or Herbal and Dietary Supplements

This webinar is targeted to AASLD Associate and Trainee members, as well as Junior Faculty. The goal is to provide an approach to the accurate diagnosis of Drug Induced Liver Injury (DILI), with special attention to considerations that may mask the diagnosis. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .Paul (Skip) Hayashi Dr. Hayashi is currently Co-Chair of the Causality Committee for the Drug-Induced Liver Injury Network (DILIN) and Associate Professor at the University of North Carolina (UNC), Chapel Hill, NC.